Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

ACTINIUM PHARMACEUTICALS, INC.

(ATNM)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur ACTINIUM PHARMACEUTICALS, INC.
12/11ACTINIUM PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
12/11Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine ..
12/11Actinium Highlights Actimab-A Combined with CD47 Immunotherapy Results in Upregulation ..
12/11SITC 2021 : Actimab-A with CD47 Immunotherapy in AML
12/11SITC 2021 : HER2 Targeted Radiotherapy with CD47 Immunotherapy in Solid Tumors
09/11ACTINIUM PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Submission of ..
05/11Actinium Announces Multiple Abstracts Highlighting Iomab-B and Actimab-A Accepted for P..
05/11Actinium Announces Completion of Enrollment of Actimab-A CLAG-M Combination Trial in Pa..
04/11Actinium Announces Completion of Enrollment of Actimab-A CLAG-M Combination Trial in Pa..
22/10NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
04/10ACTINIUM PHARMACEUTICALS : Announces Two Abstracts Highlighting Combinations of CD47 Targe..
29/09ACTINIUM PHARMACEUTICALS : to Present at the Cantor Fitzgerald Virtual Global Healthcare C..
29/09ACTINIUM PHARMACEUTICALS RALLY TAKES : Atnm)
28/09ACTINIUM PHARMACEUTICALS : Announces Expansion of R&D Team and Facilities to Accelerate Re..
28/09GENPREX : Appoints Mark Berger Chief Medical Officer
23/09ACTINIUM PHARMACEUTICALS : Announces Multiple Senior Leadership Appointments Including Chi..
23/09ACTINIUM PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Regulation FD ..
23/09Actinium Announces Multiple Senior Leadership Appointments Including Chief Business and..
23/09ACTINIUM PHARMACEUTICALS RALLY INTAC : Atnm)
21/09ACTINIUM PHARMACEUTICALS STOCK JUMPS : Atnm)
20/09ACTINIUM PHARMACEUTICALS, INC.(NYSEA : ATNM) added to S&P Global BMI Index
16/09ACTINIUM PHARMACEUTICALS : Completes Enrollment in the Pivotal Phase 3 SIERRA Trial of Iom..
15/09ACTINIUM PHARMACEUTICALS : Completes Enrollment in Phase 3 Trial of Iomab-B to Treat Leuke..
15/09Actinium Pharmaceuticals, Inc. Completes Enrollment in the Pivotal Phase 3 SIERRA Trial..
30/07ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
30/07Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended Ju..
29/06ACTINIUM PHARMACEUTICALS : Announces Inclusion in Russell Microcap Index
17/06ACTINIUM PHARMACEUTICALS : Awarded Patents in Europe, Japan for Antibody Radiation Conjuga..
15/06Actinium Pharmaceuticals, Inc. Announces Safety Data from Phase 3 SIERRA Trial of Iomab..
04/06ACTINIUM PHARMACEUTICALS : Announces Several Presentations from the Phase 3 SIERRA Study o..
03/06Actinium Pharmaceuticals, Inc. Announces Several Presentations from the Phase 3 SIERRA ..
15/05ACTINIUM : Q1 Earnings Snapshot
14/05ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
14/05Actinium Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended Mar..
01/04ACTINIUM PHARMACEUTICALS : to Participate in the Cell & Gene Meeting on the Mediterranean
31/03ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
31/03Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended Decembe..
26/03ACTINIUM PHARMACEUTICALS : Announces Completion of Enrollment of Second Dose Cohort in Act..
25/03ACTINIUM PHARMACEUTICALS : Announces Initiation of Patient Enrollment in Iomab-ACT Trial f..
25/03ACTINIUM PHARMACEUTICALS : Completes Enrollment of Second Dose Cohort of Actimab-A Venetoc..
25/03Actinium Pharmaceuticals, Inc. Announces Completion of Enrollment of Second Dose Cohort..
24/03ACTINIUM PHARMACEUTICALS : Begins Patient Enrollment for Iomab-ACT Study to Treat Leukemia..
24/03Actinium Pharmaceuticals, Inc. Announces Initiation of Patient Enrollment in Iomab-ACT ..
12/03ACTINIUM PHARMACEUTICALS : to Highlight Expansion of Targeted Conditioning Portfolio at AA..
11/03Actinium to Highlight Expansion of Targeted Conditioning Portfolio at AACR with Next-Ge..
04/03ACTINIUM PHARMACEUTICALS : Announces Appointment of Mark Kubik, MBA as Chief Business Offi..
03/03ACTINIUM PHARMACEUTICALS : Announces Participation in H.C. Wainwright Global Life Sciences..
03/03ACTINIUM PHARMACEUTICALS : Names Mark Kubik as Chief Business Officer
03/03Actinium Pharmaceuticals, Inc. Appoints Mark Kubik as Chief Business Officer
11/02ACTINIUM PHARMACEUTICALS : Safety Results with Targeted Conditioning via Iomab-B
11/02ACTINIUM PHARMACEUTICALS : Announces Participation in BIO CEO and Investor Digital Confere..
11/02Actinium Showcases Targeted Conditioning Program with 2 Oral Presentations Highlighting..
21/01ACTINIUM PHARMACEUTICALS : to Participate in a Fireside Chat at the B. Riley Oncology Inve..
14/01ACTINIUM PHARMACEUTICALS : and Astellas Announce Research Collaboration Focused on Novel -..
2020ACTINIUM PHARMACEUTICALS : Announces Successful Pre-Planned Ad Hoc Interim Analysis of Pha..
2020ACTINIUM PHARMACEUTICALS : Says Committee Recommends Continuation of Late-Stage Study of L..
2020Actinium Announces Successful Pre-Planned Ad Hoc Interim Analysis of Phase 3 SIERRA Tri..
2020ACTINIUM PHARMACEUTICALS : Highlights Presence at Targeted Radiopharmaceuticals Summit
2020ACTINIUM PHARMACEUTICALS : Reports 67 Percent Overall Response Rate in First Cohort in Act..
2020Actinium Pharmaceuticals, Inc. Reports 67% Overall Response Rate in First Cohort in Act..
2020Actinium Pharmaceuticals, Inc. Announces Positive Interim Results from Iomab-B Pivotal ..
2020Actinium Pharmaceuticals, Inc. Announces Safety Data from its Ongoing Pivotal Phase 3 S..
2020Actinium Pharmaceuticals, Inc. Presents Interim Data from Actimab-A CLAG-M Phase 1 Comb..
2020ACTINIUM PHARMACEUTICALS : Highlights Clinical Data to be presented at the Upcoming 62nd A..
2020ACTINIUM PHARMACEUTICALS : Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinic..
2020ACTINIUM PHARMACEUTICALS : Highlights Foundational Patents Covering the Composition of Apa..
2020ACTINIUM PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Submission of ..
2020ACTINIUM PHARMACEUTICALS : Strengthens Leadership Team with Appointment of Dr. Avinash Des..
2020Actinium Pharmaceuticals, Inc. Appoints Avinash Desai as Executive Vice President of Cl..
2020ACTINIUM PHARMACEUTICALS : to Participate in the Alliance Global Partners Virtual Healthca..
2020ACTINIUM PHARMACEUTICALS : Investor Presentation
2020ACTINIUM PHARMACEUTICALS : Reports 100% Remission Rate in Cohort of Phase 1 Study of Actim..
2020Actinium Pharmaceuticals, Inc. Announces 100% Remission Rate Reported in Third Dose Coh..
2020Actinium Pharmaceuticals, Inc. Announces Actimab-A Venetoclax First-In-Human Data Accep..
2020ACTINIUM PHARMACEUTICALS : Letter to Shareholders
1  2  3  4  5  6Suiv.